间变性大细胞淋巴瘤
粒体自噬
生物
癌症研究
调节器
长非编码RNA
染色质
核糖核酸
基因
淋巴瘤
遗传学
细胞凋亡
自噬
免疫学
作者
Valentina Mularoni,Benedetta Donati,Annalisa Tameni,Veronica Manicardi,Francesca Reggiani,Elisabetta Sauta,Magda Zanelli,Marco Tigano,Emanuele Vitale,Federica Torricelli,Stefano Ascani,Giovanni Martino,Giorgio Inghirami,Francesca Sanguedolce,Alessia Ruffini,Alberto Bavieri,Stefano Luminari,Marco Pizzi,Angelo Paolo Dei Tos,Cinzia Fesce,Antonino Neri,Alessia Ciarrocchi,Valentina Fragliasso
出处
期刊:Haematologica
[Ferrata Storti Foundation]
日期:2023-06-29
被引量:1
标识
DOI:10.3324/haematol.2022.282552
摘要
Long noncoding RNAs (lncRNAs) are emerging as powerful and versatile regulators of transcriptional programs and distinctive biomarkers of T-cell Lymphoma progression disease. Their role in the aggressive ALK- Anaplastic Large Cell Lymphoma (ALCL) subtype has been only in part elucidated. Starting from our previously identified ALCL-associated lncRNA signature and performing digital gene expression profiling of a retrospective cohort of ALCLs, we defined an 11 lncRNA signature able to discriminate among ALCL subtypes. We selected a not previously characterized lncRNA, MTAAT, with an ALK- ALCL preferential expression, for molecular and functional studies. We demonstrated that lncRNA MTAAT contributes to an aberrant mitochondrial turnover restraining mitophagy and promoting cellular proliferation. Functionally, lncRNA MTAAT acts as a repressor of a set of genes related to mitochondria quality control via chromatin reorganization. Collectively, our work demonstrates the transcriptional role of lncRNA MTAAT in orchestrating a complex transcriptional program sustaining ALK- ALCL progression.
科研通智能强力驱动
Strongly Powered by AbleSci AI